TITLE

Significant reduction of laparotomy-associated lung metastases and subcutaneous tumors after perioperative immunomodulation with flt3 ligand in mice

AUTHOR(S)
Carter, Joseph J.; Feingold, Daniel L.; Wildbrett, Peer; Oh, Anthony; Kirman, Irena; Asi, Zishan; Stapleton, George; Huang, Emina; Fine, Robert L.; Whelan, Richard L.
PUB. DATE
December 2005
SOURCE
Surgical Innovation;Dec2005, Vol. 12 Issue 4, p319
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Laparotomy has been associated with increased rates of tumor establishment and metastasis formation postoperatively in animal models. The purpose of this study was to determine the impact on postoperative tumor growth of perioperative upregulation of immune function via fetal liver tyrosine kinase 3 (Flt3 ligand). Two murine studies were carried out: the first utilized a lung metastases model, and the second involved a subcutaneous tumor model. Each study included four groups: anesthesia control (AC), AC plus Flt3 ligand (ACFIt3), sham laparotomy (OP), and OP plus Flt3 ligand (OPFIt3). Flt3 ligand was administered by daily intraperitoneal injection (10 µg/dose) beginning 5 days preoperatively and continuing for 1 week postoperatively. In study 1, A/J mice were given tail vein injections of 1.5 x 105 TA3Ha cancer cells on the day of surgery. The mice were sacrificed 14 days after surgery, the lungs processed, and the surface metastases counted by a blinded observer. In study 2 C3H/He mice were given a dorsal subcutaneous injection of 104 MC-2 cancer cells on the day of surgery. The mice were sacrificed 31 days after surgery, and the injection sites were evaluated for subcutaneous tumors grossly and histologically. In study 1, the median number of surface lung metastases per mouse was 166 in the OP group and 36 in the 0PFIt3 (P = .021). Mice in the AC group developed a median 50 lung metastases per animal compared with mice in the ACFIt3 group who had a median of 10 metastases per mouse (P=.001). The OP group had significantly more metastases than the AC group (P = .048). In study 2, the percentage of animals that developed tumors in the AC, OP, ACFIt3, and 0PFIt3 groups was 43, 80, 0, and 20, respectively. The incidence of tumors in the OPFLt3 group and the ACFIt3 group was significantly less than their respective control groups (P < .01). The difference between the OP and AC groups was not significant (P > .05). Perioperatively administered Flt3 ligand was associated with significantly fewer lung metastases and a lower incidence of subcutaneous tumor formation after laparotomy and anesthesia alone. Perioperative immunomodulation may limit untoward surgery-related oncologic effects.
ACCESSION #
19487622

 

Related Articles

  • Natural and therapy-induced immunosurveillance in breast cancer. Kroemer, Guido; Senovilla, Laura; Galluzzi, Lorenzo; André, Fabrice; Zitvogel, Laurence // Nature Medicine;Oct2015, Vol. 21 Issue 10, p1128 

    The immunosurveillance theory postulates that tumors evolve and progress in an uncontrolled fashion only when anticancer immune responses fail. Natural immunosurveillance clearly influences human breast cancer (BC) progression because the prognosis of BC patients is dictated by the density,...

  • VEGF-D Correlates with Metastatic Disease in Gastric Cancer Patients Undergoing Surgery. Schimanski, Carl C.; Schlaegel, Friederike; Jordan, Mareike; Moehler, Markus; Sgourakis, George; Drescher, Daniel G.; Galle, Peter R.; Lang, Hauke; Gockel, Ines // World Journal of Surgery;May2011, Vol. 35 Issue 5, p1010 

    Background: The present study was designed to evaluate the impact of the tyrosine kinase ligands VEGF-A/C/D, PDGF-A/B on tumor dissemination and survival in gastric cancer. This is the first study analyzing all these parameters in a homogeneous patient population undergoing surgery. Methods: The...

  • 4-Thiophenoxy-N-(3,4,5-Trialkoxyphenyl)Pyrimidine-2-Amines as Potent and Selective Inhibitors of the T-Cell Tyrosine Kinase p56lck. O'Connell, J.; Moffat, D. F. C.; Allen, R. A.; Rapecki, S. E.; Davis, P. D.; Hutchings, M. C.; King, M. A.; Boyce, B. A.; Perry, M. J. // Current Medicinal Chemistry;Mar2004, Vol. 11 Issue 6, p747 

    We have developed a series of 4-thiophenoxy-N-(3,4,5-trialkoxyphenyl) pyrimidine-2-amines as potent and selective inhibitors of p56lck tyrosine kinase activity. In particular, the most potent inhibitor shows cellular activity in T-cell receptor (TCR) stimulated models of cytokine release, which...

  • Excellent outcome of immunomodulation or Bruton's tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Gupta, Eva; Accurso, Joseph; Sluzevich, Jason; Menke, David M.; Han W. Tun // Rare Tumors;2015, Vol. 7 Issue 4, p164 

    Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare diffuse large B-cell lymphoma confined to the skin of the legs. The typical presentation is characterized by solitary or multiple growing plaques, usually confined to one leg. We report a case of PCDLBCL-LT of...

  • Imatinib (STI-571) heals a gastrocutaneous fistula resulting from a malignant gastric stromal tumor. Ng, Enders K.W.; Wong, Simon K.H.; Mok, Tony S.K.; Chan, W.Y.; Chung, S.C. Sydney // Gastric Cancer;Jun2003, Vol. 6 Issue 2, p122 

    The management of inoperable giant malignant gastrointestinal stromal tumor (GIST) of the stomach used to be a formidable task. We report our success with the use of STI-571 in treating a patient with huge GIST of the stomach complicated by gastrocutaneous fistula after an unsuccessful...

  • Crystal structure of an Eph receptor-ephrin complex. Himanen, Juha-Pekka; Rajashankar, Kanagalaghatta R.; Lackmann, Matin; Cowan, Chad A.; Henkemeyer, Mark; Nikolov, Dimitar B. // Nature;12/20/2001-12/27/2001, Vol. 414 Issue 6866, p933 

    Examines the crystal structure of an Eph receptor tyrosine kinases and membrane anchored ephrin ligands. Regulation of the cell to cell interactions; Process communicating information in Eph and ephrin expressing cells; Function of the Eph and ephrin molecules.

  • Angiopoietins.  // Encyclopedic Reference of Molecular Pharmacology;2004, p47 

    The article presents an encyclopedia entry for angiopoietins, which are growth factor ligands of the receptor tyrosine kinase Tie-2 that are critical regulators of vascular assembly and differentiation.

  • Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma. Hoshino, Yoshinori; Hasegawa, Hirotoshi; Ishii, Yoshiyuki; Endo, Takashi; Ochiai, Hiroki; Okabayashi, Koji; Kaneko, Gou; Mikami, Shuji; Mukai, Makio; Oya, Mototsugu; Kitagawa, Yuko // International Journal of Clinical Oncology;Aug2012, Vol. 17 Issue 4, p412 

    Sunitinib, a multitargeted tyrosine kinase inhibitor, is widely used in the treatment of carcinoma. Adverse events associated with this treatment, including fatigue, diarrhea, and hematotoxicity, have been reported in clinical trials. Bowel perforation is a surgical emergency that requires...

  • Characterization of hematopoietic precursor cell Flt3R/CD164 expression and capacity of colonization formation from different human hematopoietic tissues. Hsiao-Nan Hao; Yongtai Zhang; Jane Zhao; Guotong Xu; Yanyun Zhang // Cell Research;Aug2008 Supplement, Vol. 18, pS117 

    Hematopoietic progenitor cells (HPC) are capable of self-renewal, of differentiation into many different lineages, and have the potential to treat malignant and non-malignant diseases. The cytokine tyrosine kinase receptor flt3 is expressed, and plays a critical role in the early human...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics